Actin-Binding rho Activating Protein (ABRA) (Middle Region) Peptid
ABRA
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle ABRA Produkte
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- QWADEHIQSQ KLNPFSEEFD YELAMSTRLH KGDEGYGRPK EGTKTAERAK
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ABRA Antibody(ARP52674_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Hintergrund
-
ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling.
Alias Symbols: STARS
Protein Interaction Partner: ACTB,ACTC1
Protein Size: 381 - Molekulargewicht
- 43 kDa
- Gen-ID
- 137735
- NCBI Accession
- NM_139166, NP_631905
- UniProt
- Q8N0Z2
-
Sie sind hier:
